Immunotherapy in metastatic urothelial carcinoma: focus on immune checkpoint inhibition.

about

Immunotherapy in metastatic urothelial carcinoma: focus on immune checkpoint inhibition.

Item

http://www.wikidata.org/entity/Q47800676

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Immunotherapy in metastatic urothelial carcinoma: focus on immune checkpoint inhibition.

@en

Immunotherapy in metastatic urothelial carcinoma: focus on immune checkpoint inhibition.

@nl

type

Item

label

Immunotherapy in metastatic urothelial carcinoma: focus on immune checkpoint inhibition.

@en

Immunotherapy in metastatic urothelial carcinoma: focus on immune checkpoint inhibition.

@nl

prefLabel

Immunotherapy in metastatic urothelial carcinoma: focus on immune checkpoint inhibition.

@en

Immunotherapy in metastatic urothelial carcinoma: focus on immune checkpoint inhibition.

@nl

P1476

Immunotherapy in metastatic urothelial carcinoma: focus on immune checkpoint inhibition.

@en

P2093

Arlene Siefker-Radtke

http://www.w3.org/2001/XMLSchema#string

Brendan Curti

http://www.w3.org/2001/XMLSchema#string

P2860

The human PD-1 gene: complete cDNA, genomic organization, and developmentally regulated expression in B cell progenitors

Mutational heterogeneity in cancer and the search for new cancer-associated genes

Nivolumab plus ipilimumab in advanced melanoma.

The blockade of immune checkpoints in cancer immunotherapy

The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation

PD-1 Pathway Inhibitors: Immuno-Oncology Agents for Restoring Antitumor Immune Responses

PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations

Myeloid-derived suppressor cells as regulators of the immune system

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

PD-L2 is a second ligand for PD-1 and inhibits T cell activation

P2888

nrurol.2017.190

P304

112-124

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1038/NRUROL.2017.190

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29205200

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy